KELUN PHARMA(SZ:002422) Xin Lang Cai Jing·2025-10-24 01:37Core Viewpoint - On October 23, 2023, Kelun Pharmaceutical experienced a decline of 3.04% in stock price, with a trading volume of 362 million yuan, indicating market volatility and investor sentiment towards the company [1]. Financing and Trading Activity - On the same day, Kelun Pharmaceutical had a financing buy-in amount of 47.32 million yuan and a financing repayment of 34.36 million yuan, resulting in a net financing buy of 12.96 million yuan. The total financing and securities balance reached 936 million yuan [1]. - The current financing balance of 933 million yuan represents 1.68% of the circulating market value, which is above the 60th percentile level over the past year, indicating a relatively high financing level [1]. - In terms of securities lending, 5,900 shares were repaid, and 10,200 shares were sold short, amounting to 355,000 yuan at the closing price. The remaining short-selling volume was 80,000 shares, with a balance of 2.784 million yuan, which is below the 50th percentile level over the past year, suggesting a lower level of short interest [1]. Company Financial Performance - As of June 30, 2025, Kelun Pharmaceutical reported a total revenue of 9.083 billion yuan for the first half of the year, reflecting a year-on-year decrease of 23.20%. The net profit attributable to shareholders was 1.001 billion yuan, down 44.41% compared to the previous year [2]. - Since its A-share listing, Kelun Pharmaceutical has distributed a total of 6.898 billion yuan in dividends, with 3.587 billion yuan distributed over the past three years [2]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Kelun Pharmaceutical reached 34,200, an increase of 2.55% from the previous period. The average number of circulating shares per shareholder decreased by 2.49% to 38,138 shares [2]. - Among the top ten circulating shareholders, notable changes include an increase in holdings by China Europe Medical Health Mixed A (003095) by 12.6942 million shares, while Hong Kong Central Clearing Limited reduced its holdings by 2.7086 million shares [3].